Clinical Trial

Defining Dosimetric Reference Levels in Computed Tomography Spectral Scanning

Study acronym: NR Spectral
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 26, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Spectral computed tomography or dual-energy CT imaging can overcome the limitations of conventional CT in differentiating between two materials with equivalent total attenuation. It can generate several types of images, such as virtual monochromatic images, which improve the contrast-to-noise ratio for low energy levels and reduce artifacts for high energy levels. It also allows for quantitative image analysis and thus better characterization of lesions and tissues through material mapping (e.g., iodinated contrast agent mapping). This technique is increasingly used in routine clinical practice thanks to improvements in image flow management and technological advances. It also involves exposing patients to ionizing radiation, as with conventional CT but, unlike conventional CT scans, for which dosimetric reference levels (RLs) are defined for the most common examinations in France (RL decree dated 2019), there are currently no dosimetric reference levels for examinations performed using this technique. Yet RLs are an important and effective tools for optimizing patient exposure to ionizing radiation. Several articles were published between 2012 and 2017 when the first dual-energy scanners arrived in clinics. However, the results presented in these studies are now far removed from recent practices, as they do not take into account the latest technological developments used in dual-energy scanners, which reduce X-ray doses. The main objective of the study is to define dosimetric reference levels for the most commonly performed spectral computed tomography examinations in France.
Trial Details
NCT Number NCT07305103
Lead Sponsor Centre Hospitalier Universitaire de Nīmes
Collaborators: Institut Paoli Calmettes, Marseille, Hôpital Necker-Enfants Malades, University Hospital, Lille, Hopital Lariboisière, Centre Hospitalier Universitaire de Saint Etienne, Saint-Louis Hospital, Paris, France, Bichat Hospital, Hôpital Louis Mourier, 92700 Colombes, Centre Hospitalier de Valenciennes, Hopital Louis Pradel, Centre Léon Bérard, Lyon, University Hospital, Bordeaux, Centre Hospitalier Lyon Sud, Institut Curie, Amiens University Hospital, Poitiers University Hospital, Henri Mondor Hospital, Créteil, Saint Antoine University Hospital, Nord Ardennes Intercommunal Hospital, Centre Antoine Lacassagne, Nice, Hôpital Edouard Herriot (GH Centre), Lyon
Conditions Medical Imaging
Enrollment 9,600 participants
Start Date 2025-09-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-26